Cancer cells may release some factors to enhance angiogenesis, and the surrounding tissues may adjust to accommodate the growing mass.
Feeder cells may release growth factors into the media or assist in the removal of toxic substances, and development rates can double or more in the presence of some form of helper cell.
They may release chemotactic factors and a variety of mediators.
It has been postulated that heparanase may release growth factors such as FGF from the surrounding tissue (eg basement membrane) thus initiating angiogenesis and contributing to tumourigenesis.
The inflammatory response may be beneficial, reflecting the role of inflammation as a host defense response to injury and promoting the regeneration of surviving neurons or it may release toxic factors that amplify tissue damage which can lead to poor functional recovery following SCI [ 37].
Endothelial cells are known to contain small intracellular granules that may release several inflammatory factors, including CCL2, more rapidly than the content of Weibel-Palade bodies [ 31, 32].
Moreover, activated astrocytes may release, among different factors, Hsps [ 52, 53], which could induce the Abeta aggregation, reducing its potential toxicity [ 36, 38, 40].
This finding led to the hypothesis that coating plasma proteins on the wells may release heat-labile factors which inhibit the binding of fibrinogen to coated ferritin.
Indeed, prior bone resorption may release preformed growth factors necessary to trigger the anabolic effect of teriparatide (Oreffo et al 1989).
For example, microglia that invade the brain and optic nerves during demyelination may release several trophic factors including BDNF, which stimulate oligodendrocyte protection.
